New AIM admission: AOTI Inc eyes $12bn market

Medical technology company AOTI Inc has developed products that help to heal wounds by focusing oxygen on chronic wounds. These can include diabetic foot ulcers and pressure ulcers. The company acquired a negative pressure wound therapy device.

Diabetes levels are increasing, and this will provide the core market. The estimated global market for the company’s technology is $12bn. That requires regulatory approvals in additional geographic markets.  

The board decided to come to AIM i...

You are unauthorized to view this page.

Latest News

More Articles Like This

Tagdiv Cloud library - template content.